Long-term follow-up of VIALE-C in patients with untreated AML ineligible for intensive chemotherapy.
Wei, Andrew H ; Panayiotidis, Panayiotis ; Montesinos, Pau ; Laribi, Kamel ; Ivanov, Vladimir ; Kim, Inho ; Novak, Jan ; Champion, Rebecca ; Fiedler, Walter ; Pagoni, Maria ... show 10 more
Wei, Andrew H
Panayiotidis, Panayiotis
Montesinos, Pau
Laribi, Kamel
Ivanov, Vladimir
Kim, Inho
Novak, Jan
Champion, Rebecca
Fiedler, Walter
Pagoni, Maria
Citations
Altmetric:
Affiliation
Other Contributors
Publication date
2022-12-22
Subject
Collections
Research Projects
Organizational Units
Journal Issue
Abstract
No abstract available
Citation
Wei AH, Panayiotidis P, Montesinos P, Laribi K, Ivanov V, Kim I, Novak J, Champion R, Fiedler W, Pagoni M, Bergeron J, Ting SB, Hou JZ, Anagnostopoulos A, McDonald A, Murthy V, Yamauchi T, Wang J, Jiang Q, Sun Y, Chyla B, Mendes W, DiNardo CD. Long-term follow-up of VIALE-C in patients with untreated AML ineligible for intensive chemotherapy. Blood. 2022 Dec 22;140(25):2754-2756. doi: 10.1182/blood.2022016963
Type
Article